Chinese medicinal composition for treating primary aldosteronism

Abstract

The invention discloses a Chinese medicinal composition for treating primary aldosteronism. The composition comprises self-heal, uncaria, antifebrile dichroa branchlet and leaf, eucommia, concha haliotidis, motherwort fruit, roots of uraria crinit, dutchmanspipe root, earthworm, manyprickle acanthopanax root, kudzuvine root, sophora japonica, scutellaria root, hawthorn, epimedium, evodia, harlequin glorybower leaf and twig, pinellia ternate, white peony root, radix ophiopogonis, dried radix rehmanniae, motherwort, petasites japonicas, sophora flavescens, habenariacilio, kelp, corydalis decumbentis and mesona chinensis. Multiple gouts of Chinese medicaments serving as raw materials are scientifically compatible and synergic, so that the composition has the effects of nourishing yin and blood, calming liver and removing blood stasis, reducing blood pressure and descending adverse qi, can effectively treat renal hypertension, is short in treatment course, quick in response and high in treatment rate, and is thus worthy of popularization.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating primary aldosteronism. Background technique [0002] Primary aldosteronism (referred to as primary aldosteronism) is a hypertensive and hypokalemic syndrome caused by excessive aldosterone secretion from the adrenal cortex. Conn first pointed out in 1955 that excessive aldosterone secretion by adrenal cortical adenomas is the cause of this disease, so it is also called Conn syndrome. The disease accounts for 1 to 2% of hospitalized hypertension cases and is a curable secondary hypertension. However, if the course of the disease is too long, long-term high blood pressure and severe hypokalemia can also cause serious harm. Aldosterone hypersecretion includes primary and secondary. Primary aldosteronism is caused by excessive secretion of aldosterone by adrenal lesions, while secondary aldosteronism is caused by ...

AI Technical Summary

Problems solved by technology

For inoperable tumors and patients with idiopathic hyperplasia (without surgery or with unsatisfactory results after surgery), spironolactone should be used for treatment. The usage is the same as the preparation before surgery. Long-term use of spironolactone can cause gynecomastia and impotence. Disorder and other side effects can be changed to triamterene or amiloride to help excrete sodium and potassium, and antihypertensive drugs should be added if necessary, but many patients tend to become dependent on drugs, and they are prone to relapse once the drug is stopped